Page 943 - Cardiac Nursing

/
0
0
9
9
/
/
2
2
6
6
/
9
20.
20.
20.
6-9
6-9
6-9
d
2
2
qx
qx
d
009
19
19
19
g
e 9
e 9
ar
a
a
Apt
Apt
ar
g
1
1:2
1:2
009
009
1
M
Pa
Pa
0 P
0 P
M
p90
p90
K34
K34
LWB
LWBK340-c41_p906-920.qxd 29/06/2009 11:20 PM Page 919 Aptara
K34
LWB
41_
0-c
41_
0-c
CHAP TER 4 1 / Complementary and Alternative Approaches in Cardiovascular Disease 919
46. Dickinson, H. O., Mason, J. M., Nicolson, D. J., et al. (2006), Lifestyle 69. Roselle, H., Ekatan, A., Tzeng, J., et al. (2008). Symptomatic hepatitis
interventions to reduce raised blood pressure: A systematic review of ran- associated with the use of herbal red yeast rice. Annals of Internal Medicine,
4
4
domized controlled trials. Journal of Hypertension, 24(2), 215–233. 149(7), 516–517.
47. Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., et al. (2002). Blood pres- 70. Robbers, J. E., & Tyler, V. E. (1999). Tyler’s herbs of choice: The thera-
sure response to fish oil supplementation: Metaregression analysis of ran- peutic use of phytomedicinals. New York: The Haworth Herbal Press.
domized trials. Journal of Hypertension, 20(8), 1493–1499. 71. Wigger-Alberti, W., Bauer, A., Hipler, U. C., et al. (1999). Anaphylaxis
4
s
48. Covington, M. B. (2004). Omega-3 fatty acids. American Family Physi- due to Monascus purpureus-fermented rice (red yeast rice). Allergy, 54,
4
s
cian, 70(1), 133–140. 1330–1331.
49. Mori, T. A., Burke, V., Puddey, I. B., et al. (2000). Purified eicosapen- 72. Prasad, G. V., Wong, T., Meliton, G., et al. (2002). Rhabdomyolysis due
taenoic and docosahexaenoic acids have differential effects on serum to red yeast rice (Monascus purpureus) in a renal transplant recipient.
s
s
4
4
lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly Transplantation, 74, 1200–1201.
hyperlipidemic men. American Journal of Clinical Nutrition, 71, 73. Kantola, T., Kivisto, K. T., & Neuvonen, P. J. (1998). Grapefruit juice
1085–1094. greatly increases serum concentrations of lovastatin and lovastatin acid.
50. Contacos, C., Barter, P. J., & Sullivan, D. R. (1993). Effect of pravastatin Clinical Pharmacological Therapy, 63, 397–402.
and omega-3 fatty acids on plasma lipids and lipoproteins in patients 74. Heber, D., Lembertas, A., Lu, Q. Y., et al. (2001). An analysis of nine
with combined hyperlipidemia. Arteriosclerosis Thrombosis, 13, proprietary Chinese red yeast rice dietary supplements: Implications of
1755–1762. variability in chemical profile and contents. Journal of Alternative and
7
51. Suzukawa, M., Abbey, M., Howe, P. R., et al. (1995). Effects of fish oil Complement Medicine, 7, 133–139.
7
fatty acids on low density lipoprotein size, oxidizability, and uptake by 75. Vogel, J. H. K., Bolling, S. F., Olshansky, B., et al. (2005). Integrating
6
6
macrophages. Journal of Lipid Research, 36, 473–484. complementary medicine into cardiovascular medicine. Journal of the
6
6
52. Vessby, B., & Boberg, M. (1990). Dietary supplementation with n-3 American College of Cardiology, 46(1), 184–221.
fatty acids may impair glucose homeostasis in patients with non-insulin- 76. Isaacsohn, J. L., Moser, M., Stein, E. A., et al. (1998). Garlic powder and
8
dependent diabetes mellitus. Journal of Internal Medicine, 228, 165–171. plasma lipids and lipoproteins, a multicenter, randomized, placebo-
8
53. Farmer, A., Montori, V., Dinneen, S., et al. (2001). Fish oil in people controlled trial. Archives of Internal Medicine, 158, 1189–1194.
8
with type 2 diabetes mellitus. Cochrane Database Systematic Review, 3, 77. Berthold, H. K., Sudhop, T., & von Bergmann, K. (1998). Effect of a
CD003205. garlic oil preparation on serum lipoproteins and cholesterol metabolism.
54. Schectman, G., Kaul, S., Cherayil, G. D., et al. (1989). Can the hy- JAMA, 279(23), 1900–1902.
potriglyceridemic effect of fish oil concentrate be sustained? Annals of In- 78. Stevinson, C., Pittler, M. H., & Ernst, E. (2000). Garlic for treating hy-
ternal Medicine, 110, 346–352. percholesterolemia: a meta-analysis of randomized clinical trials. Annals
0
0
55. Brown, J. E., & Wahle, K. W. (1990). Effect of fish oil and vitamin E of Internal Medicine, 133, 420–429.
supplementation on lipid peroxidation and whole blood aggregation in 79. Yeh, Y. Y., & Liu, L. (2001). Cholesterol-lowering effect of garlic extracts
man. Clinica Chimica Acta, 193, 147–156. and organosulfur compounds: Human and animal studies. Journal of
56. Yamori, Y., Nara, Y., Mizushima, S., et al. (1994). Nutritional factors for Nutrition, 131(3s), 989S–93S.
stroke and major cardiovascular diseases: International epidemiological 80. Gebhardt, R., & Beck, H. (1996). Differential inhibitory effects of
comparison of dietary prevention. Health Report, 6, 22–67. garlic-derived organosulfur compounds on cholesterol biosynthesis in
6
6
57. Pedersen, H. S., Mulvad, G., Seidelin, K. N., et al. (1999). N-3 fatty primary rat hepatocyte cultures. Lipids, 31, 1269–1276.
acids as a risk factor for haemorrhagic stroke. Lancet, 353, 812–813. 81. Silagy, C., & Neil, A. (1994). Garlic as a lipid lowering agent—A meta-
8
8
58. Cunnane, S. C., Ganguli, S., Menard, C., et al. (1993). High alpha- analysis. Journal of the Royal College of Physicians (London), 28, 39–45.
linolenic acid flaxseed (Linum usitatissimum): Some nutritional proper- 82. Rahman, K., & Billington, D. (2000). Dietary supplementation with
ties in humans. British Journal of Nutrition, 69, 443–453. aged garlic extract inhibits ADP-induced platelet aggregation in humans.
9
9
59. Cunnane, S. C., Hamadeh, M. J., Liede, A. C., et al. (1995). Nutritional Journal of Nutrition, 130(11), 2662–2265.
attributes of traditional flaxseed in healthy young adults. American Jour- 83. Chutani, S. K., & Bordia, A. (1981). The effect of fried versus raw gar-
8
nal of Clinical Nutrition, 61, 62–68. lic on fibrinolytic activity in man. Atherosclerosis, 38, 417–421.
60. Bierenbaum, M. L., Reichstein, R., & Watkins, T. R. (1993). Reducing 84. Natural Medicines Comprehensive Database. (2008) Retrieved October
atherogenic risk in hyperlipemic humans with flaxseed supplementation: 10, 2008, from http://www.naturaldatabase.com
A preliminary report. Journal of the American College of Nutrition, 12(5), 85. Piscitelli, S. C., Burstein, A. H., Welden, N., et al. (2002). The effect
501–504. of garlic supplements on the pharmacokinetics of saquinavir. Clinics in
4
61. Jenkins, D. J., Kendall, C. W. C, Vidgen, E., et al. (1999). Health aspects Infectious Disease, 34, 234–238.
4
of partially defatted flaxseed, including effects on serum lipids, oxidative 86. Morisco, C., Trimarco, B., & Condorelli, M. (1993). Effect of coenzyme
measures, and ex vivo androgen and progestin activity: A controlled, Q10 therapy in patients with congestive heart failure: A long-term, mul-
crossover trial. American Journal of Clinical Nutrition, 69, 395–402. ticenter, randomized study. Clinical Investigation, 71(Suppl. 8),
9
9
62. Prasad, K. (1997). Dietary flax seed in prevention of hypercholes- S134–S136.
terolemic atherosclerosis. Atherosclerosis, 132, 69–76. 87. Hofman-Bang, C., Rehnqvist, N., Swedberg, K., et al. (1995). Coen-
2
2
63. Allman, M. A., Pena, M. M., & Pang, D. (1995). Supplementation with zyme Q10 as an adjunctive treatment of congestive heart failure. Journal
flaxseed oil versus sunflower seed oil in healthy young men consuming a of Cardiac Failure, 1, 101–107.
low fat diet: Effects on platelet composition and function. European 88. Mortensen, S. A. (2000). Coenzyme Q10 as an adjunctive therapy in pa-
9
9
Journal of Clinical Nutrition, 49(3), 169–178. tients with congestive heart failure. Journal of the American College of
6
6
64. Iso, H., Sato, S., Umemura, U., et al. (2002). Linoleic acid, other fatty Cardiology, 36, 304–305.
acids, and the risk of stroke. Stroke, 33(8), 2086–2093. 89. Singh, R. B., Niaz, M. A., Rastogi, S. S., et al. (1999). Effect of hy-
s
s
65. Li, C., Zhu, Y., Wang, Y., et al. (1995). Monascus purpureus-fermented drosoluble coenzyme Q10 on blood pressures and insulin resistance in
rice (red yeast rice): a natural food product that lowers blood cholesterol hypertensive patients with coronary artery disease. Journal of Human
in animal models of hypercholesterolemia. Nutrition Research, 18, Hypertension, 13, 203–208.
71–81. 90. Rosenfeldt, F. L., Haas, S. J., Krum, H., et al. (2007). Coenzyme Q10 in
66. Wei, W., Li, C., Wang, Y., et al. (2003). Hypolipidemic and anti-athero- the treatment of hypertension: A meta-analysis of the clinical trials. Journal
s
s
genic effects of long-term Cholestin (Monascus purpureus-fermented rice, of Human Hypertension, 21(4), 297–306.
red yeast rice) in cholesterol fed rabbits. Journal of Nutrition and Bio- 91. Liu, L., Ikeda, K., Sullivan, D. H., et al. (2002). Epidemiological evidence
4
chemistry, 14(6), 314–318. of the association between dietary protein intake and blood pressure: A
4
67. Heber, D., Yip, I., Ashley, J. M., et al. (1999). Cholesterol-lowering effects meta-analysis of published data. Hypertension Research, 25, 689–695.
5
5
of a proprietary Chinese red-yeast-rice dietary supplement. American 92. He, J., Gu, D., Wu, X., et al. (2005). Effect of soybean protein on blood
Journal of Clinical Nutrition, 69, 231–236. pressure: A randomized, controlled trial. Annals of Internal Medicine, 43,
9
9
68. Downs, J. R., Clearfield, M., Weis, S., et al. (1998). Primary prevention 1–9.
of acute coronary events with lovastatin in men and women with average 93. Burke, V., Hodgson, J. M., Beilin, L. J., et al. (2001). Dietary protein
cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary and soluble fiber reduce ambulatory blood pressure in treated hyperten-
Atherosclerosis Prevention Study. JAMA, 279(20), 1615–1622. sives. Hypertension, 38(4), 821–826.